SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. on September 6, 2022, reporting an event that occurred on September 2, 2022. The company is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance regarding stock listing status.
Material Changes
The primary material change reported is the resolution of a Nasdaq listing deficiency. Previously, on July 14, 2022, the company received notice that its stock price had fallen below the $1.00 minimum bid price requirement for 30 consecutive business days. On September 2, 2022, Nasdaq confirmed that the company regained compliance because the closing bid price remained at or above $1.00 for 10 consecutive business days (August 19, 2022, to September 2, 2022).
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of future risks beyond the immediate resolution of the listing compliance matter. The matter regarding the minimum bid price requirement is now closed.
Investor Verification Checklist
- Verify the current trading price of BSGM to ensure it remains above the $1.00 threshold to avoid future delisting notices.
- Confirm the company's status on the NASDAQ Capital Market via the exchange's official website.
- Review subsequent filings for any new compliance issues or financial updates, as this 8-K contains no financial data.